|
KMID : 1225720230150060725
|
|
Allergy, Asthma & Immunology Research : AAIR
2023 Volume.15 No. 6 p.725 ~ p.756
|
|
|
KAAACI Guidelines for Allergen Immunotherapy
|
|
Lee Hwa-Young
Lee Sang-Min
Kang Sung-Yoon
Kim Kyung-Hoon
Kim Ju-Hee
Ryu Gwang-Hui
Min Jin-Young
Park Kyung-Hee
Park So-Young
Sung Myong-Soon
Lee Young-Soo
Yang Eun-Ae
Jee Hye-Mi
Ha Eun-Kyo
Shin Yoo-Seob
Chung Eun-Hee
Choi Sun-Hee
Koh Young-Il
Kim Seon-Tae
Nahm Dong-Ho
Park Jung-Won
Shim Jung-Yeon
An Young-Min
Han Doo-Hee
Han Man-Yong
Lee Yong-Won
Choi Jeong-Hee
|
|
|
Abstract
|
|
|
|
Allergen immunotherapy (AIT) is a causative treatment for various allergic diseases such as allergic rhinitis, allergic asthma, and bee venom allergy that induces tolerance to offending allergens. The need for uniform practice guidelines in AIT is continuously growing because of the increasing discovery of potential candidates for AIT and evolving interest in new therapeutic approaches. This guideline is an updated version of the Korean Academy of Asthma Allergy and Clinical Immunology recommendations for AIT published in 2010. This updated guideline proposes an expert opinion by allergy, pediatrics, and otorhinolaryngology specialists with an extensive literature review. The guideline deals with basic knowledge and methodological aspects of AIT, including mechanisms, clinical efficacy, patient selection, allergens extract selection, schedule and doses, management of adverse reactions, efficacy measurements, and special consideration in pediatrics. The guidelines for sublingual immunotherapy will be covered in detail in a separate article.
|
|
|
KEYWORD
|
|
|
Allergens, immunotherapy, guideline
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|
|